A clinical trial to compare the combined effects of biologic agent with allografts in the treatment of bone defects in molars.
- Conditions
- Health Condition 1: K053- Chronic periodontitis
- Registration Number
- CTRI/2022/09/045881
- Lead Sponsor
- DR CHING NUN SIAM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Patients with good systemic and mental health with no systemic diseases that could influence
the outcome of the therapy.
• Patients having Glickmanâ??s Grade II Molar Furcation involvement with horizontal probing depth
guided tissue regeneration of >=3mm and vertical probing depth of >=4mm.
Patients who are maintaining oral hygiene, after the re-evaluation of phase I therapy with
Plaque index (PI) score <1.
• Patients who have not undergone any surgical periodontal therapy in last 6 months.
• Patients who had no known history of allergy to any of the materials used.
• Patients who are ready to sign informed consent and will be able to follow written or verbal
instructions.
Debilitating systemic or infectious diseases (HIV or hepatitis) or any diseases that affect the
periodontium.
A known allergy to any of the materials used in the study.
Poor compliance or failure to maintain good oral hygiene.
Pregnancy or lactation
Use of tobacco products either in smoking or smokeless forms.
Patients taking immunosuppressive drugs or corticosteroids which may compromise the
treatment outcome.
History of a previous root coverage procedure, graft or GTR involving the recession site.
Failure to complete the informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method